Clinical trial
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
NCT01100099 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- September 30, 2012
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
celiac disease, gluten